Table 2.

Genetic and biochemical basis for diagnosis of the 14 DADA2 patients

Patient IDCECR1 allele 1CECR1 allele 2ADA2 activity pre-HSCTADA2 activity post-HSCT
P001 c.1110C>A (p.N370K) c.1072G>A (p.G358R) 0.6* 19.7 at 1 y* 
P002 c.794C>G (p.S265X) c.794C>G (p.S265X) 0.0* 10.8 at 1 y* 
P003 c.660C>A (p.Y220X) c.660C>A (p.Y220X) 2.5 NA 
P004 c.506G>A (p.R169Q) c.506G>A (p.R169Q) 0.8* 7.0 at 1 y* 
P005 c.144delG (p.R49fs) c.506G>A (p.R169Q) NA NA 
P006 c.144dupG (p.R49fs) c.506G>A (p.R169Q) NA NA 
P007 c.506G>A (p.R169Q) c.506G>A (p.R169Q) NA 15.3 at 3 mo* 
P008 c.506G>A (p.R169Q) c.506G>A (p.R169Q) NA 22.07* 
P009 c.506G>A (p.R169Q) c.506G>A (p.R169Q) 0.11* NA 
P010 c.506C>T (p.R169Q) c.2T>C (p.M1T) NA NA 
P011 c.506G>A (p.R169Q) c.506G>A (p.R169Q) NA NA 
P012 c.140G>T (p.G47V) c.336C>G (p.H112Q) NA NA 
P013 c.144del (p.R49fs) c.47+2T>C (splice site) 0.2* 11.7* 
P014 c.506G>A (p.R169Q) c.1072G>A (p.G358R) NA 22.3* 
Patient IDCECR1 allele 1CECR1 allele 2ADA2 activity pre-HSCTADA2 activity post-HSCT
P001 c.1110C>A (p.N370K) c.1072G>A (p.G358R) 0.6* 19.7 at 1 y* 
P002 c.794C>G (p.S265X) c.794C>G (p.S265X) 0.0* 10.8 at 1 y* 
P003 c.660C>A (p.Y220X) c.660C>A (p.Y220X) 2.5 NA 
P004 c.506G>A (p.R169Q) c.506G>A (p.R169Q) 0.8* 7.0 at 1 y* 
P005 c.144delG (p.R49fs) c.506G>A (p.R169Q) NA NA 
P006 c.144dupG (p.R49fs) c.506G>A (p.R169Q) NA NA 
P007 c.506G>A (p.R169Q) c.506G>A (p.R169Q) NA 15.3 at 3 mo* 
P008 c.506G>A (p.R169Q) c.506G>A (p.R169Q) NA 22.07* 
P009 c.506G>A (p.R169Q) c.506G>A (p.R169Q) 0.11* NA 
P010 c.506C>T (p.R169Q) c.2T>C (p.M1T) NA NA 
P011 c.506G>A (p.R169Q) c.506G>A (p.R169Q) NA NA 
P012 c.140G>T (p.G47V) c.336C>G (p.H112Q) NA NA 
P013 c.144del (p.R49fs) c.47+2T>C (splice site) 0.2* 11.7* 
P014 c.506G>A (p.R169Q) c.1072G>A (p.G358R) NA 22.3* 
*

Plasma ADA2 (mU/mL): healthy controls (n = 20 + pooled normal plasma), 14.2 ± 5.2 (4.8-27.2); DADA2 patients (n = 25), 0.4 ± 0.5 (0.02-1.7).

Dried plasma spots ADA2 (mU/g protein): healthy controls (n = 39), 130.5 ± 49.8 (58-271); DADA2 patients (n = 40), 4.4 ± 4.3 (0.04-17.2).

Siblings.

Close Modal

or Create an Account

Close Modal
Close Modal